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ABSTRACT 
 
Background: The Copper-T (Cu-T) Intrauterine device (IUD) is one of the oldest and most reliable 
forms of contraception. Its widespread use has been limited by side effects, such as heavy 
menstrual flow and pain on insertion. Findings suggest that the intrauterine device acts more as a 
contraceptive than an abortifacient, thus improving its acceptability. 
Objectives: To determine the proportion of women using Cu-T IUD, who will develop side effects 
during the study period; Outline experienced side effects of Cu-T; and ascertain the discontinuation 
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rate and reasons for removal. 
Methods: The intrauterine device used for this study is Copper T380A. 
A descriptive cohort study, of women using Cu-T IUD at the Jos University Teaching Hospital, 
North Central Nigeria. A structured proforma was used to extract data from family planning 
records. Study duration was one year. (Jan-Dec 2007). 
Results: A total of 103 women participated in the study. The average age of the respondents was 
30.75 ± 5.90 years, with a range of 20-47 years. Only a few (17.5%) of the respondents had side 
effects or complications, The commonest side effect was vaginal discharge and abnormal 
cessation of menstrual flow (5.8%) respectively. Other side effects documented were painful period 
(2.9%) and abdominal pain (1%). Only 5.8% (n=6) discontinued the Cu-T IUD, due to side effects. 
The commonest reason for discontinuation was abdominal pain, 1.97% (n=2), although only one 
client had initially reported abdominal pain as an adverse effect. There was a significant 
relationship between development of side effects and discontinuation. (p <0.01). 
Conclusion: Only a few of the women using Cu-T IUD developed side effects, and discontinuation 
rate was quite low. Patients who discontinued usage did so because of side effects and husband’s 
request. Limitations of this study include the short duration of follow up. 
Public health education should be done to enlighten Nigerian women on this method of 
contraception which seems quite tolerable and reliable, with the aim of increasing its uptake.  
 
 
Keywords: Copper-T; Intra-Uterine Device; contraceptive. 
 
1. INTRODUCTION  
 
The Copper-T (Cu-T) Intra-Uterine Device (IUD) 
is one of the oldest and most reliable forms of 
contraception. Findings suggest that the 
intrauterine device acts more as a contraceptive 
rather than an abortifacient, thus improving its 
acceptability [1]. The high effectiveness of intra-
uterine contraceptive device is shown in a global 
cumulative pregnancy rate of less than 2% at 5 
years [2]. With particular reference to the Cu T 
IUD, failure rates of less than 2 per 100 woman 
years have been documented [3]. Copper-T 
provides long-lasting (as long as twelve years) 
and highly effective contraception [2]. Other 
advantages include relative affordability, it does 
not interrupt the process of sexual intercourse 
and hormonal side effects are eliminated since it 
does not contain hormones [2,4]. Despite the 
advantages of using the CU-T intra-uterine 
device, its widespread use have been limited                 
by reported side effects, such as heavy 
menstrual flow and pain on insertion [5,6]. 
Nulliparous women have been shown to exhibit 
peculiar side-effects that include increased 
bleeding, higher expulsion rates and subsequent 
removal [7,8]. Overall compliance with the use of 
the CU -T intra-uterine device has generally been 
shown to be good [9]. The extent to which 
development of side effects has led to 
discontinuation of usage is an area that needs 
further exploration, thus necessitating this study. 
This study sought to determine the proportion of 
women using Cu-T IUD who developed side 
effects; to outline experienced side effects of  
Cu-T; And to ascertain the discontinuation rate 
and reasons for removal. 
 
2. MATERIALS AND METHODS 
 
2.1 Study Site  
 
The study site was University of Jos Teaching 
Hospital, Jos. Jos, the capital city of Plateau 
State, is a town situated in the North-central part 
of Nigeria. 
 
2.2 Methods  
 
The intrauterine device used for this study is 
Copper T380A. 
 
A descriptive cohort study of women using Cu T-
IUD at the Family planning clinic of Jos 
University Teaching Hospital.  
 
Patients who present to the Family planning 
clinic of Jos University Teaching Hospital go 
through a process of counselling on the various 
options available for contraception. The merits 
and demerits of all the methods are discussed 
with them and they are allowed to ask questions.  
 
When all questions have been exhausted, the 
patient then decides on a method and completes 
a proforma for that particular method before the 
method is administered. 
 
Every patient who chose Cu-T IUD at the family 
planning clinic (January to June 2007) and gave 
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informed consent, was enrolled into the study, 
and followed up till December 2007. Total 
number of study participants was 103.  
 
A structured proforma was used to extract 
variables such as biodata, Cu-T insertion date, 
patients’ complains at follow-up appointments 
(including, adverse effects); Request for removal 
of Cu-T and reason for the request and removal 
date from the family planning register. 
 
2.3 Statistical Analysis  
 
Statistical analysis (descriptive statistics and chi 
square test for association) was carried out using 
SPSS version 20. 
 
Informed consent was obtained from participants 
after they had studied the information sheet 
provided. Literate participants signed while 
illiterate participants thumb-printed in the 
presence of a witness after explanation of the 
study in their local dialects. Participants who 
were not interested in reading the participant’s 
information and participate were excluded from 
the study but this did not affect the quality of 
family planning services they received. 
 
Ethical approval for the study was obtained from 
the Ethics Review Committee of Faculty of 
Medical Sciences, University of Jos. 
Administrative approval was obtained from the 
University of Jos Teaching Hospital. 
 
3. RESULTS  
 
The average age of the respondents was 30.75 ± 
5.90 years, with a range of 20-47 years             
(Table 1). Only 17.5% (n=18) of the respondents  
suffered side effects or complications (Table 2). 
The commonest adverse effect was vaginal 
discharge seen in 5.8% (n=6) of the 
respondents; and abnormal cessation of 
menstrual flow which occurred in 5.8% (n=6) of 
the patients. Other adverse effects documented 
are abdominal pain 1.0% (n=1), inter-menstrual 
bleeding 1.0% (n=1) and Heavy menstrual 
bleeding 1.0% (n=1). Only 5.8% (n=6) 
discontinued the Cu –T IUD due to adverse 
effects. The commonest reason for 
discontinuation (Table 3) was abdominal pain 
1.9% (n=2) and husband’s request 1.9% (n=2). 
There was no relationship between, age of 
respondents and development of side effects 
(p=0.13) but there was a significant relationship 
between discontinuation and development of 
side effects (p <0.01). 
Table 1. Demographic characteristics of 
respondents 
 
Age % (n) 
20 – 30 57.28 (59) 
31 – 40 37.87 (39) 
41 – 50 4.85 (5) 
Total 100.00 (103) 
Parity % (n) 
0 4.85 (5) 
1 - 3 50.49(52) 
4 – 6 36.89 (38) 
7 – 9 7.77 (8) 
Total 100 (103) 
 
Table 2. Types of complications developed by 
clients while on Cu-T IUD 
 
Adverse effects/complications % (n) 
Abdominal pain 0.98 (1) 
Inter menstrual bleeding 0.98 (1) 
Heavy menstrual bleeding 0.98 (1) 
Painful menstruation 2.91 (3) 
Abnormal cessation of menstrual 
flow 
5.83 (6) 
Vaginal discharge 5.83 (6) 
None 82.52 (85) 
Total 100 (103)                                                                                              
 
Table 3. Reasons for removal of IUD and 
continuation   
 
Reason % (n) 
Infection 0.97 (1) 
Wants a baby 0.97 (1) 
Abdominal pain 1.94 (2) 
Husband request 1.94 (2) 
Continuation rate 94.17 (97) 
Total 100 (103) 
 
4. DISCUSSION  
 
This study has shown that most of the acceptors 
of the CU- T Intrauterine contraceptive device will 
not develop side effects or complications. This 
method of contraception also showed a good 
spread of usage among women within the 
reproductive age group as reflected by age 
ranging from 20 years to 47 years. 
 
This spread of usage within a broad age range is 
a testament of the fact that the CU-T IUD is well 
accepted across various age range and thus 
debunking the “myth” that the IUD is not a 
preferred method by younger women of low 
parity. As a matter of fact, majority of women fall 
within the 20-30 age group reflecting 57% of 
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respondents and the other 43% within the 31-50 
age group. This is a good balance of spread 
within the age range. There is also no 
relationship between the age of the respondents 
and the development of side-effect. It was 
thought that younger nulliparous patients tend to 
have more side effects and higher rate of 
expulsion [10]. This however has not been 
supported by this study. 
  
This study showed that parity did not influence 
acceptance of the Cu- T IUD as 55.4% of 
respondents fall within the parity of 0-3. The 
others are distributed within a parity range of 4-7. 
This further buttress the suggestion that women 
of varied age range and parity will accept the use 
of the Cu-T IUD as against the usual stereotype 
that acceptors of the intrauterine contraceptive 
device will be women of high parity tending 
towards the later part of their reproductive life.  
Women of varied ages and parity can thus safely 
use intrauterine contraceptive device. This view 
is also supported by Speroff & Darney [11,12]. In 
spite of the low proportion of women in the study 
who developed side effects or complication, a 
further lower portion (5.8%) of overall users 
actually discontinued the method of 
contraception out of this, only 2.9% requested 
IUD removal because of side effect. This finding 
further supports the fact that most of the 
documented side effects were actually tolerable 
by the acceptors of this method of contraception 
[3]. Other reasons for removal were due to the 
request of the husband and desire to conceive.  
The instrument used did not probe further to 
know why the husbands requested removal of 
IUD. 
 
Abnormal uterine bleeding has been known to 
account for a major reason for removal of the  
CU -T IUD [13]. This was not observed in this 
study as abnormal uterine bleeding as a side-
effect was seen in only 2% of the respondents. It 
is also interesting to note that vaginal discharge 
and abnormal cessation of menstrual flow were 
respectively seen as an adverse effect in 5.8% of 
the respondents as the commonest side effects 
but did not influence request for removal of IUD. 
This finding negates the expectation that 
abnormal uterine bleeding is the commonest side 
effect seen in acceptors of CU-T IUD as 
demonstrated by one study [14]. The possible 
explanation could be that most cases of 
abnormal uterine bleeding demonstrated in 
acceptors of CU-T IUD may actually be linked to 
other causes of abnormal uterine bleeding rather 
than the Cu –T IUD.  
5. CONCLUSION 
 
Majority of the women using Cu T IUD did not 
develop side effects, and discontinuation rate 
was quite low. Public health education should be 
done to encourage uptake of this method of 
contraception since acceptability and tolerability 
of this method of contraception appears to be 
quite favourable. This can ultimately lead to the 
reduction of the high unmet need for 
contraception observed in Nigeria. 
 
6. LIMITATION OF STUDY  
 
The major limitation of this study is the small 
sample size, findings from this study will 
therefore require further studies with a larger 
sample size to corroborate or refute. 
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